Medical and Pharmaceutical TG Therapeutics stock spikes on strong financials and optimism for its flagship drug The company's product for relapsing forms of multiple sclerosis (RMS), is its primary source of its most recent success Joseph MortonMarch 3, 2025
Health & Wellness Poseida Therapeutics shares skyrocket on acquisition from pharma-giant Roche Poseida's proprietary non-viral gene engineering technology has delivered promising early clinical results Joseph MortonNovember 26, 2024